Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classificação em ações #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preço da ação
$0.39
Valor de mercado
$13.79M
Variação (1 dia)
-13.53%
Variação (1 ano)
-68.80%
País
IL
Negociar NeuroSense Therapeutics Ltd. (NRSN)

Categoria

Histórico de preços das ações de NeuroSense Therapeutics Ltd. (NRSN)
Preço de fecho mais alto: $0.47 em 2026-08-01

Preço de fecho mais baixo: $3.04 em 2021-12-01
Histórico de preços das ações da NeuroSense Therapeutics Ltd. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE